Apcn2010.org

Speaker’s Profile
-Sylvia Ramirez-
Speaker's Sylvia Ramirez
Organization Arbor Research
Department Global Research and
- Children’s Hospital of Boston, Harvard Medical School Education - Univ. of Chicago Graduate School of Business
- Harvard School of Public Health Present: Vice President, Global Research and Development at Arbor Research - Principal Investigator, for several high health policy research projects with Centers for Medicare and Medicaid Services (CMS), USA - Masters in Public Health, Harvard Medical School of Public Health - Assistant Professor, National Univ. of Singapore’s Pediatric Transplant and Nephrology Experience
program; While on faculty, she developed a nationwide kidney disease screening program for the pediatric population, which evolved to become a program of the - Chief, Prevention of the National Kidney Foundation Singapore; upon recognizing significant shortcomings in the Singapore health systems to deal with patients with chronic disease, particularly diabetes and hypertension, she developed and implemented a comprehensive approach to the prevention of kidney and related - Ramirez SP, Albert JM, Blayney MJ, Tentori F, Goodkin DA, Wolfe RA, Young EW, Bailie GR, Pisoni RL, Port FK. Rosiglitazone is associated with mortality in chronic hemodialysis patients. J Am Soc Nephrol 2009 May; 20(5): 1094-101. - Tentori F, Elder SJ, Thumma J, Pisoni RL, Bommer J, Fissel RB, Fukuhara S, Jadoul M, Keen ML, Saran R, Ramirez SPB, Robinson BM. Physical Exercise Among Participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Correlates and Associated Specific
Outcomes. Nephrol Dial Transplant, in press. - Lopes AA, Bragg-Gresham JL, Ramirez SP, et al. Prescription of anti hypertensive Publication
agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS. Nephrol Dial Transplant 2009 - Ramirez SP, Albert JM, Blayney MJ, Tentori F, Goodkin DA, Wolfe RA, Young EW, Bailie GR, Pisoni RL, Port FK. Rosiglitazone is associated with mortality in chronic hemodialysis patients. J Am Soc Nephrol 2009 May; 20(5): 1094-101. Dr. Sylvia Ramirez is now the Vice President of Global Research and Development at Arbor Research Collaborative for Health, which is based in Ann Arbor, Michigan and is a co-investigator for the Dialysis Outcomes and Practice Pattern or DOPPS study. In Summary addition, Dr. Ramirez Principal Investigator for several high health policy research
projects with Centers for Medicare and Medicaid Services (CMS), in the USA, on areas such as the ESRD Quality Measures Project, the Quality Incentive Payment Demonstration and the Disease Management Demonstration Evaluation. Your profile has been shortened to fit our database system. For any questions or comments on the edited file, please feel free to contact the APCN2010 Secretariat at [email protected]

Source: http://www.apcn2010.org/03_program/Speakers_Profile/Sylvia%20Ramirez_IS89.pdf